Unjha Formulations Ltd Q1 FY27 Profit Falls 59.76% to ₹0.16 Cr

Unjha Formulations Ltd reported a net profit of ₹0.16 crore for the quarter ended June 2026, down 59.76% from ₹0.39 crore a year earlier, as revenue declined 8.98% to ₹3.31 crore. The company returned to profit from a loss in the preceding quarter, but its year-on-year operating performance remained lower.

What did Unjha Formulations report for Q1 FY27?

Unjha Formulations Ltd reported standalone net sales of ₹3.31 crore in Q1 FY27, compared with ₹3.63 crore in Q1 FY26. The 8.98% year-on-year decline also followed a marginal 0.60% fall from ₹3.33 crore reported in the March 2026 quarter.

Net profit stood at ₹0.16 crore, or ₹15.69 lakh, against ₹0.39 crore in the corresponding quarter of the previous year. Earnings per share fell to ₹0.35 from ₹0.90 in June 2025. The quarterly result therefore showed weaker year-on-year profit and revenue, despite a return to positive earnings from the March 2026 quarter.

The June 2026 quarter was considered by the board on August 3, 2026. The meeting was scheduled at the company's registered office in Sidhpur, Gujarat, to approve unaudited financial results for the quarter ended June 30, 2026, under SEBI's Listing Obligations and Disclosure Requirements regulations.

How did the June quarter compare with the previous quarter?

Unjha Formulations returned to a net profit of ₹0.16 crore in June 2026 after reporting a net loss of ₹0.74 crore in March 2026. This sequential movement represents a 121.62% improvement in net profit on the basis of the reported quarterly comparison.

Operating profit was ₹0.20 crore in June 2026, compared with an operating loss of ₹0.45 crore in the preceding quarter. Operating profit margin improved to 5.74% from negative 13.51% in March 2026. Total expenditure declined to ₹3.11 crore from ₹3.78 crore over the same period, while net sales were broadly stable at ₹3.31 crore versus ₹3.33 crore.

The sequential recovery should be read alongside the March-quarter base, which included an operating loss and net loss. On a year-on-year basis, operating profit declined from ₹0.42 crore in June 2025 to ₹0.20 crore in June 2026, while the operating margin declined from 11.57% to 5.74%.

What are the key Q1 FY27 financial figures?

The key Q1 FY27 figures show that Unjha Formulations restored profitability sequentially, but sales, operating profit and net profit were below the levels recorded a year earlier.

The company reported revenue of ₹3.31 crore in the June quarter, while some summary data rounded the figure to ₹3.3 crore. The detailed standalone quarterly figures provide the more precise revenue, operating profit and net profit numbers used in the comparison.

Why does the result matter for Unjha Formulations?

The result matters because Unjha Formulations is a supplier and manufacturer of isabgol products in India, and its quarterly numbers show pressure on both sales and profitability compared with the previous year. Revenue has moved below the June 2025 level, while operating margin has nearly halved year on year.

The June-quarter performance also needs to be viewed against the company's annual results. Revenue increased to ₹15.75 crore in the year ended March 2026 from ₹13.98 crore in March 2025. Annual EBITDA rose to ₹1.10 crore from ₹0.63 crore, and annual net profit increased to ₹0.70 crore from ₹0.41 crore. Thus, the annual record showed improvement, while the first quarter of FY27 started with a weaker year-on-year comparison.

For investors, the return to profit from the March-quarter loss is a reported positive sequential development. However, the lower revenue, operating profit and earnings per share versus June 2025 remain the relevant indicators of the company's year-on-year performance in Q1 FY27.

When will Unjha Formulations announce Q2 FY27 results?

Unjha Formulations has scheduled a board meeting on November 5, 2026, to consider its Q2 FY27 results for the July-September 2026 period. The announced date is the next reported earnings event following the June-quarter results.

The Q2 update will provide the next disclosed comparison for revenue, operating profitability and net profit after the June-quarter recovery from the March-quarter loss. The provided information does not include trailing twelve-month financial data or a management outlook, so the scheduled board meeting remains the next identified corporate event for financial disclosures.

Conclusion

Unjha Formulations reported Q1 FY27 revenue of ₹3.31 crore and net profit of ₹0.16 crore. While the company moved back into profit from the ₹0.74 crore loss reported in the preceding quarter, its revenue fell 8.98% and net profit declined 59.76% from the June 2025 quarter.

The next item to watch is the board meeting scheduled for November 5, 2026, when Unjha Formulations is set to consider Q2 FY27 results. That disclosure will show whether the sequential improvement in profitability recorded during the June quarter continued into the July-September period.